Warning lights
Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.
-
Two loss years in a row NBB
Negative result in 2023 and 2024.
Financials
Financial year 2024
GUANG JI Pharmaceutical Belgium sa from Ottignies-Louvain-la-Neuve, company number BE0718983596, closed financial year 2024 with a result of € -19,155 after tax. For that financial year GUANG JI Pharmaceutical Belgium sa recorded a gross margin of € -17,711 and equity of € 12,203. Compared with financial year 2023, the result moved from € -11,191 to € -19,155. The company made a loss. The buffer shrank hard: equity is 61 % below last year. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on August 11, 2025.
€ 12,203
▼ 61% vs 2023
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ -19,155
▼ 71 % more loss than in 2023
Profit after tax over the fiscal year.
€ 16,149
▼ 35% vs 2023
Cash and bank balances on the last day of the fiscal year.
Loss, nothing to pay out
Reserves fell to € -87,702.
Debts at end 2024
None
No bank loans on the last day of the fiscal year.
€ 13,545
▲ € 10,514 vs 2023
Supplier invoices still open on the last day of the fiscal year.
Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →
| 2021 | 2022 | 2023 | 2024 | Change 2023 → 2024 | |
|---|---|---|---|---|---|
| Gross margin | € -7,648 | € -9,693 | € -10,605 | € -17,711 | ▼ € 7,106 |
| Profit after taxes | € -8,135 | € -10,272 | € -11,191 | € -19,155 | ▼ € 7,964 |
| Equity | € 52,820 | € 42,549 | € 31,358 | € 12,203 | ▼ 61% |
| Total debts | € 14,408 | € 3,041 | € 3,059 | € 13,545 | ▲ € 10,486 |
| Cash | € 56,239 | € 38,222 | € 24,834 | € 16,149 | ▼ 35% |
| Retained profit | € -47,085 | € -57,356 | € -68,547 | € -87,702 | ▼ € 19,155 |
| Balance sheet total | € 67,228 | € 45,590 | € 34,417 | € 25,748 | ▼ 25% |
Key figures of GUANG JI Pharmaceutical Belgium sa, fiscal years 2021 to 2024, from the annual accounts filed with the National Bank of Belgium.The annual account for fiscal year 2025 has not been filed yet; it was expected before 31 July 2026.
What happened to GUANG JI Pharmaceutical Belgium sa?
What happened at GUANG JI Pharmaceutical Belgium sa in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- Zhe FANG stepped down as director. NBB
- Ridong Xia stepped down as director. NBB
- Bin ZHENG stepped down as director. NBB
- New annual accounts for financial year 2024: loss of € 19,155. filed late Source: NBB ↗
- Zhe FANG became a director. NBB
- Ridong Xia became a director. NBB
- Bin ZHENG became a director. NBB
- Mingfeng HU stepped down as director. NBB
In short
From € 8,135 loss in 2021 to € 19,155 loss in 2024.
A new publication or filing at GUANG JI Pharmaceutical Belgium sa? We notify you, reason included.
Follow GUANG JI Pharmaceutical Belgium saDatabakkes Pro
Know what changes at your customers, suppliers and competitors. Without reading an annual account.
- Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
- We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
- In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.
Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.
De Lijn 8 June 2026 New annual account 2025
filed on 8 June 2026
What was left
€ 20 k ▼ 91%
Money in the bank
€ 178 k ▼ 98%
Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit
Management
Directors
According to the 2024 annual accounts
Zhe FANG
Director
since 2025 · until 2031
Ridong Xia
Director
since 2025 · until 2031
Bin ZHENG
Director
since 2025 · until 2031
Mingfeng HU
Director
· until 2025
Zhengdong LU
Director
since 2019 · until 2025
Establishments
Establishment units
Physical locations of this company
Fond des Més 5/18
1348 Ottignies-Louvain-la-Neuve
Rue Laid Burniat 3
1348 Ottignies-Louvain-la-Neuve
Active since 22 January 2019
Who else lives here?
A building full of entrepreneurs or one very busy letterbox? Another 6 companies are registered at this address.
All companies at this address →UNITED INVESTMENT EUROPE
€ -1,560 gross margin · 2024
Belgium H&Zedical
€ -3,948 gross margin · 2024
YUAN FENG
AMI Fires
€ -17,006 gross margin · 2024
VERENIGING VAN CHINESE DESKUNDIGEN IN BELGIE
+1 more
What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Details
- Company number
- 0718.983.596
- VAT number
- BE 0718.983.596
- Registered office
- Fond des Més 5/18, 1348 Ottignies-Louvain-la-Neuve
- Names & denominations
- GUANG JI Pharmaceutical Belgium sa
- Enterprise type
- Rechtspersoon
- Legal form
- Public limited company
- Legal situation
- Normale toestand
- Start date
- 22 January 2019
- Peppol
- Active · Active since 30 Dec 2025
- Activities · NACE
Activiteiten van adviesbureaus op het gebied van bedrijfsvoering en overig managementadvies
Overige adviesbureaus op het gebied van bedrijfsbeheer; adviesbureaus op het gebied van bedrijfsvoering
Groothandel in farmaceutische en medische artikelen